Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00428142
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2007-01-25
Brief Title:
Bortezomib Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkins Lymphoma
Sponsor:
Organization:
Canadian Cancer Trials Group